#inform-video-player-1 .inform-embed { margin-top: 10px; margin-bottom: 20px; } #inform-video-player-2 .inform-embed { margin-top: 10px; margin-bottom: 20px; } NEW YORK–(BUSINESS WIRE)–Aug 23, 2023– Ajax Therapeutics, Inc., a biopharmaceutical company applying computational chemistry and structure-based technologies to develop next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), today announced the appointment of David P. Steensma, MD, FACP, […]
Key Points Question How does surgical approach affect long-term patient survival after excision of pathologically confirmed, localized, early-stage Merkel cell carcinoma (MCC)? Findings In this national cohort study of 2313 adults, excision of pathologically confirmed, localized, early-stage MCC with Mohs micrographic surgery was associated with significantly improved overall survival compared with wide local excision. Meaning […]
August 22, 2023 Endometriosis diagnostics. Tumor detection. Blood-based biomarkers. Bone repair. These are just a handful of the medical solutions Arizona State University researchers and Mayo Clinic doctors aim to explore through an innovative funding opportunity concentrated on collaboration between physicians and academics. Sixteen pilot studies will be explored through the Mayo Clinic and Arizona […]
Tetyana Furmanets, CRNP, MSN Although patients with myeloproliferative neoplasms (MPN) often experience many symptoms either related to the disease or from treatment itself, nurses can help patients navigate symptom management and help seek relief, one expert said. Oncology Nursing News® spoke with Tetyana Furmanets, CRNP, MSN, an oncology nurse practitioner at Penn Medicine Abramson Cancer […]
August 22, 2023 The Biodesign Institute at Arizona State University continues its mission to improve human health and quality of life by welcoming nine dynamic new faculty members. Extending Biodesign’s breadth of expertise across biology, chemistry, physics, engineering, materials science and medicine, these scholars bring innovative approaches to demanding challenges in health, sustainability and society. […]
Developers plan to initiate clinical trials evaluating the efficacy and safety of MAb-AR20.5 in those with pancreatic cancer in the future. The FDA has granted orphan drug designation to IgG1k type murine monoclonal antibody MAb-AR20.5 for patients diagnosed with pancreatic cancer,1 according to a press release from CanariaBio Inc.1 The investigational monoclonal antibody is designed […]
Patients with myeloproliferative neoplasm (MPN) may experience several side effects related to treatment or the disease itself, but discussing these with their care team can help manage the symptoms, one expert said. CURE® spoke with Tetyana Furmanets, an oncology nurse practitioner at Penn Medicine Abramson Cancer Center in Philadelphia, to learn more about the symptoms […]
